Highlights
- Top ASX 200 Retirement Shares: CSL and QBE
- Retirement Portfolio Picks: CSL and QBE Shine
- Strong Returns Expected from CSL and QBE in ASX 200
If you are in the process of building a retirement portfolio, consider the quality ASX 200 shares listed below. These shares are anticipated to generate strong returns for investors. Here's what you need to know about them:
CSL Ltd (ASX:CSL)
CSL Ltd is a biotechnology giant renowned for its expertise in plasma therapies, vaccines, and kidney disease treatments. The company's diversified portfolio and innovative approach have made it a standout player in the biotech industry. According to Morgans, CSL shares are currently undervalued, trading at a discount to their long-term averages. This suggests that there is significant upside potential. Macquarie analysts are even more bullish, assigning an outperform rating and a $330.00 price target to CSL shares. They forecast robust earnings growth over the next few years, indicating that the shares could climb to $500 within three years. This growth potential, combined with CSL's strong market position, makes it an attractive option for a retirement portfolio.
QBE Insurance Group Ltd (ASX: QBE)
QBE Insurance Group is a leading global insurer with a strong presence in multiple markets. Its broad range of insurance products and services has positioned it well to capitalize on favorable market conditions. Goldman Sachs recently highlighted QBE's potential, citing the current favorable trading environment. They have set a $20.50 price target for QBE shares, indicating a potential upside of 20% over the next 12 months. Furthermore, QBE is expected to provide attractive dividend yields, which are forecasted to be 5.25% in FY 2024 and 5.6% in FY 2025. These yields offer a steady income stream for investors, enhancing its appeal as a retirement portfolio staple. With its strong market position and promising growth outlook, QBE Insurance is a compelling choice for those looking to build a robust retirement portfolio.